Outcome of patients with hip or knee OA from 12 months’ to 24 months’ follow up (n = 128)
| 12 Months | 24 Months | |||||
|---|---|---|---|---|---|---|
| Mean | (SD) | ES (95% CI) | Mean | (SD) | ES (95% CI) | |
| *p<0.05. | ||||||
| Explanations are given in the footnotes to table 3. | ||||||
| WOMAC | ||||||
| Pain | 3.95* | (2.38) | 0.25 (0.00 to 0.49) | 3.93* | (2.39) | 0.26 (0.01 to 0.50) |
| Stiffness | 4.28 | (2.41) | 0.10 (−0.14 to 0.35) | 4.37 | (2.49) | 0.07 (−0.18 to 0.31) |
| Function | 4.14 | (2.31) | 0.07 (−0.17 to 0.32) | 4.31 | (2.36) | 0.00 (−0.25 to 0.24) |
| Global | 4.11 | (2.27) | 0.12 (−0.13 to 0.36) | 4.23 | (2.31) | 0.06 −(0.18 to 0.31) |
| SF-36 | ||||||
| PF | 41.3 | (23.3) | 0.07 (−0.17 to 0.32) | 42.0 | (24.8) | 0.11 (−0.14 to 0.35) |
| RP | 29.9 | (38.6) | 0.16 (−0.09 to 0.40) | 35.7* | (41.1) | 0.33 (0.08 to 0.58) |
| BP | 38.5* | (20.9) | 0.50 (0.25 to 0.76) | 38.3* | (22.0) | 0.49 (0.24 to 0.74) |
| GH | 56.5 | (20.6) | −0.04 (−0.28 to 0.21) | 54.8 | (19.5) | −0.12 (−0.19 to −0.30) |
| VT | 46.1 | (20.9) | 0.01 (−0.23 to 0.26) | 47.0 | (22.1) | 0.06 (−0.32 to 0.17) |
| SF | 68.2 | (26.8) | −0.05 (−0.29 to 0.20) | 67.4 | (27.4) | −0.08 (−0.32 to 0.17) |
| RE | 54.6 | (45.0) | 0.02 (−0.23 to 0.26) | 57.3 | (47.1) | 0.08 (0.17 to 0.32) |
| MH | 65.7 | (18.8) | −0.03 (−0.28 to 0.21) | 64.4 | (20.5) | −0.10 (−0.35 to −0.14) |
| PCS | 32.3* | (9.6) | 0.24 (−0.01 to 0.49) | 32.8* | (10.6) | 0.30 (0.05 to 0.55) |
| MCS | 48.6 | (11.5) | −0.05 (−0.30 to 0.19) | 48.1 | (12.7) | −0.09 (−0.34 to −0.15) |